Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas

Summary

The purpose of this study is to test the effectiveness and safety of the NovoTTF-200A device in patients with low-grade glioma when it's used by itself or used together with temozolomide. Researchers would also like to know whether the use of NovoTTF-200A, with or without temozolomide, is associated with fewer negative side effects on mental function that may be seen with other currently used treatment options.

Timeline

Start

2017-04-17

Primary completion

2020-07-27

Completion

2020-07-27

Drugs

Indications